{"id":1244,"date":"2023-02-02T12:57:16","date_gmt":"2023-02-02T11:57:16","guid":{"rendered":"https:\/\/www.fda-stiftung.de\/imprint\/"},"modified":"2024-02-08T16:48:24","modified_gmt":"2024-02-08T15:48:24","slug":"site-notice","status":"publish","type":"page","link":"https:\/\/www.fda-stiftung.de\/en\/site-notice\/","title":{"rendered":"Site Notice"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\n\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\n\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t
\n\t\t\t\n\t\n\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Site Notice<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Information pursuant to Sect. 5 German Telemedia Act (TMG)<\/h2>

FDA Studentenwohnheime GmbH & Co. eGbR
Ludwig-Erhard-Stra\u00dfe 5
91052 Erlangen<\/p>

Registration court: Amtsgericht F\u00fcrth<\/p>

Represented by:<\/strong>
Dr. G\u00fcnther Zembsch,
Dr. Carola Zembsch<\/p>

Contact<\/h2>

Phone: 09131\/22033
E-mail: info@fds-stiftung.de<\/p>

EU dispute resolution<\/h2>

The European Commission provides a platform for online dispute resolution (ODR): https:\/\/ec.europa.eu\/consumers\/odr\/<\/a>.
Our e-mail address can be found above in the site notice.<\/p>

Dispute resolution proceedings in front of a consumer arbitration board<\/h2>

We are not willing or obliged to participate in dispute resolution proceedings in front of a consumer arbitration board.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Additional Information<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

FDA Studentenwohnheime GmbH & Co. eGbR is made up of two shareholders: an association<\/strong> (FDS e.V.<\/em>) and a foundation<\/strong> (FDA Stiftung<\/em>).<\/p>

Both the association (F\u00f6rdererkreis Deutscher Studenten e.V.<\/em>) and the foundation (F\u00f6rderung der Ausbildung gemeinn\u00fctzige Stiftung<\/em>) are recognized as non-profit by the tax office.<\/p>

Thanks to this non-profit status, we have the opportunity to offer housing at particularly favorable conditions, from which the students benefit.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Site Notice Information pursuant to Sect. 5 German Telemedia Act (TMG) FDA Studentenwohnheime GmbH & Co. eGbRLudwig-Erhard-Stra\u00dfe 591052 Erlangen Registration court: Amtsgericht F\u00fcrth Represented by:Dr. G\u00fcnther Zembsch,Dr. Carola Zembsch Contact Phone: 09131\/22033E-mail: info@fds-stiftung.de EU dispute resolution The European Commission provides a platform for online dispute resolution (ODR): https:\/\/ec.europa.eu\/consumers\/odr\/.Our e-mail address can be found above in […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1244","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/pages\/1244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/comments?post=1244"}],"version-history":[{"count":7,"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/pages\/1244\/revisions"}],"predecessor-version":[{"id":1887,"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/pages\/1244\/revisions\/1887"}],"wp:attachment":[{"href":"https:\/\/www.fda-stiftung.de\/en\/wp-json\/wp\/v2\/media?parent=1244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}